Xiaonan Zhang

Direct interaction between alpha-actinin and hepatitis C virus NS5B.

Hepatitis C virus non-structural protein NS5A interacts with FKBP38 and inhibits apoptosis in Huh7 hepatoma cells.

Inhibition of hepatitis B virus replication by MyD88 is mediated by nuclear factor-kappaB activation.

Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1.

Computational analyses of JAK1 kinase domain: subtle changes in the catalytic cleft influence inhibitor specificity.

Desflurane preconditioning inhibits endothelial nuclear factor-kappa-B activation by targeting the proximal end of tumor necrosis factor-alpha signaling.

Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients.

HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells.

A random PCR screening system for the identification of type 1 human herpes simplex virus.

Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation.

Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.

Hepatitis B virus polymerase impairs interferon-α-induced STA T activation through inhibition of importin-α5 and protein kinase C-δ.

Plasma microRNA profile as a predictor of early virological response to interferon treatment in chronic hepatitis B patients.

Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: evaluation of antiviral efficacy in a murine infection model.

Comparison of circulating, hepatocyte specific messenger RNA and microRNA as biomarkers for chronic hepatitis B and C.

PCR for detection of oseltamivir resistance mutation in influenza A(H7N9) virus.

Genetic and phenotypic characterization of Candida albicans strains isolated from infectious disease patients in Shanghai.

Oral administered particulate yeast-derived glucan promotes hepatitis B virus clearance in a hydrodynamic injection mouse model.

Infection of inbred BALB/c and C57BL/6 and outbred Institute of Cancer Research mice with the emerging H7N9 avian influenza virus.

Drug susceptibility profile and pathogenicity of H7N9 influenza virus (Anhui1 lineage) with R292K substitution.

Extra-pulmonary viral shedding in H7N9 Avian Influenza patients.

Hepatitis B virus spliced variants are associated with an impaired response to interferon therapy.

A Pilot Study of MicroRNAs Expression Profile in Serum and HBsAg Particles: Predictors of Therapeutic Vaccine Efficacy in Chronic Hepatitis B Patients.

The discovery and characterization of a novel scaffold as a potent hepatitis C virus inhibitor.

In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection.

Clinicopathologic characteristics of HIV/AIDS-related plasmablastic lymphoma.

Functional integration of a serotonergic neuron in the Drosophila antennal lobe.

MicroRNA-939 restricts Hepatitis B virus by targeting Jmjd3-mediated and C/EBPα-coordinated chromatin remodeling.

PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.

Label-free Proteomic Analysis of Exosomes Derived from Inducible Hepatitis B Virus-Replicating HepAD38 Cell Line.

Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis.

Predictive model for inflammation grades of chronic hepatitis B: Large-scale analysis of clinical parameters and gene expressions.

Identified Serotonergic Modulatory Neurons Have Heterogeneous Synaptic Connectivity within the Olfactory System of Drosophila.

Establishment of a fluorescent in situ hybridization assay for imaging hepatitis B virus nucleic acids in cell culture models.

Circulating miR-210 and miR-22 combined with ALT predict the virological response to interferon-alpha therapy of CHB patients.

Differentially Expressed Intrahepatic Genes Contribute to Control of Hepatitis B Virus Replication in the Inactive Carrier Phase.

Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays.

Extracellular Hepatitis B Virus RNAs Are Heterogeneous in Length and Circulate as Capsid-Antibody Complexes in Addition to Virions in Chronic Hepatitis B Patients.

Long-term functional maintenance of primary human hepatocytes in vitro.

A two-step lineage reprogramming strategy to generate functionally competent human hepatocytes from fibroblasts.